Analyst firms · Morgan Stanley · NVRO
Morgan Stanley NVRO price target and rating history
Nevro Corp. (NVRO) · Health Care
Morgan Stanley rates Nevro Corp. (NVRO) Underweight with a $4 price target, as of its latest action on Dec 2, 2024. It has published 4 rating actions on NVRO since August 2021, including 0 upgrades and 2 downgrades.
- Current rating
- Underweight
- Price target
- $4
- Median target, all firms
- Too few
- Actions on NVRO
- 4
Morgan Stanley price target on NVRO
Every Morgan Stanley rating on NVRO
- Dec 2, 2024
- Feb 25, 2022
- Jan 7, 2022
- Aug 5, 2021
Questions about Morgan Stanley and NVRO
- What is Morgan Stanley's price target for NVRO?
- Morgan Stanley's latest stated price target for Nevro Corp. (NVRO) is $4, from its action on Dec 2, 2024.
- What is Morgan Stanley's rating on NVRO?
- Morgan Stanley rates NVRO Underweight, a bearish rating, as of Dec 2, 2024.
- When did Morgan Stanley last change its view on NVRO?
- On Dec 2, 2024, Morgan Stanley downgrades to Underweight from Equal-Weight, price target $9 to $4.
More NVRO rating histories
- Piper Sandler5
- Wells Fargo8
- Citigroup5
- Canaccord Genuity4
- Robert W. Baird4
- Truist Securities3
- Leerink Partners3
All Morgan Stanley ratingsNVRO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.